The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
NMI HLDGS INC | CL A | 629209305 | 1,816 | 238,309 | SH | SOLE | 238,309 | 0 | 0 | ||
TORONTO DOMINION BK ONT | NOTE 3.625% 9/1 | 891160MJ9 | 15,068 | 15,000,000 | PRN | SOLE | 0 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 1,462 | 59,572 | SH | SOLE | 59,572 | 0 | 0 | ||
WOORI BK GLBL MEDIUM TERM SU | PRFD 4.500%12/3 | 98105HAE0 | 11,000 | 11,000,000 | PRN | SOLE | 0 | 0 | 0 |